Illumina Stock Net Income

ILMN Stock  USD 149.70  0.16  0.11%   
As of the 29th of January, Illumina retains the Risk Adjusted Performance of 0.1426, market risk adjusted performance of 0.6712, and Downside Deviation of 1.82. Illumina technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Illumina Total Revenue

5.28 Billion

Illumina's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Illumina's valuation are provided below:
Gross Profit
2.9 B
Profit Margin
0.164
Market Capitalization
23 B
Enterprise Value Revenue
5.7223
Revenue
4.3 B
We have found one hundred twenty available fundamental trends for Illumina, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to confirm Illumina's regular fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 29th of January 2026, Market Cap is likely to grow to about 1.6 B. Also, Enterprise Value is likely to grow to about 1.6 B This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Loss-1.1 B-1 B
Net Loss-1.1 B-1 B
Net Loss-1.1 B-1 B
Net Loss(8.45)(8.03)
Net Income Per E B T 0.94  0.66 
As of the 29th of January 2026, Net Loss is likely to grow to about (1 B). In addition to that, Net Loss is likely to grow to about (1 B).
  
Build AI portfolio with Illumina Stock

Latest Illumina's Net Income Growth Pattern

Below is the plot of the Net Income of Illumina over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Illumina financial statement analysis. It represents the amount of money remaining after all of Illumina operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Illumina's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Illumina's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (1.22 B)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Illumina Net Income Regression Statistics

Arithmetic Mean(195,713,744)
Geometric Mean453,978,116
Coefficient Of Variation(672.48)
Mean Deviation935,976,033
Median151,254,000
Standard Deviation1,316,126,999
Sample Variance1732190.3T
Range5.4B
R-Value(0.46)
Mean Square Error1458945.3T
R-Squared0.21
Significance0.06
Slope(119,546,367)
Total Sum of Squares27715044.5T

Illumina Net Income History

2026-1 B
2025-1.1 B
2024-1.2 B
2023-1.2 B
2022-4.4 B
2021762 M
2020656 M

Other Fundumenentals of Illumina

Illumina Net Income component correlations

Illumina Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Illumina is extremely important. It helps to project a fair market value of Illumina Stock properly, considering its historical fundamentals such as Net Income. Since Illumina's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Illumina's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Illumina's interrelated accounts and indicators.
Will Life Sciences Tools & Services sector continue expanding? Could Illumina diversify its offerings? Factors like these will boost the valuation of Illumina. Market participants price Illumina higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Illumina data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.78)
Earnings Share
4.46
Revenue Per Share
27.356
Quarterly Revenue Growth
0.004
Return On Assets
0.0915
Illumina's market price often diverges from its book value, the accounting figure shown on Illumina's balance sheet. Smart investors calculate Illumina's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Illumina's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Illumina 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Illumina's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Illumina.
0.00
10/31/2025
No Change 0.00  0.0 
In 3 months and 1 day
01/29/2026
0.00
If you would invest  0.00  in Illumina on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Illumina or generate 0.0% return on investment in Illumina over 90 days. Illumina is related to or competes with Quest Diagnostics, Waters, Medpace Holdings, Zimmer Biomet, Hologic, Tenet Healthcare, and ICON PLC. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis More

Illumina Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Illumina's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Illumina upside and downside potential and time the market with a certain degree of confidence.

Illumina Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Illumina's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Illumina's standard deviation. In reality, there are many statistical measures that can use Illumina historical prices to predict the future Illumina's volatility.
Hype
Prediction
LowEstimatedHigh
149.53151.63153.73
Details
Intrinsic
Valuation
LowRealHigh
134.87152.38154.48
Details
Naive
Forecast
LowNextHigh
147.47149.56151.66
Details
25 Analysts
Consensus
LowTargetHigh
123.71135.94150.89
Details

Illumina January 29, 2026 Technical Indicators

Illumina Backtested Returns

Illumina appears to be very steady, given 3 months investment horizon. Illumina holds Efficiency (Sharpe) Ratio of 0.16, which attests that the entity had a 0.16 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Illumina, which you can use to evaluate the volatility of the firm. Please utilize Illumina's Market Risk Adjusted Performance of 0.6712, downside deviation of 1.82, and Risk Adjusted Performance of 0.1426 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Illumina holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of 1.01, which attests to a somewhat significant risk relative to the market. Illumina returns are very sensitive to returns on the market. As the market goes up or down, Illumina is expected to follow. Please check Illumina's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Illumina's current trending patterns will revert.

Auto-correlation

    
  0.79  

Good predictability

Illumina has good predictability. Overlapping area represents the amount of predictability between Illumina time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Illumina price movement. The serial correlation of 0.79 indicates that around 79.0% of current Illumina price fluctuation can be explain by its past prices.
Correlation Coefficient0.79
Spearman Rank Test0.8
Residual Average0.0
Price Variance58.54
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Illumina Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

26.57 Million

At this time, Illumina's Accumulated Other Comprehensive Income is very stable compared to the past year.
Based on the recorded statements, Illumina reported net income of (1.22 Billion). This is 458.35% lower than that of the Life Sciences Tools & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is significantly higher than that of the company.

Illumina Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Illumina's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Illumina could also be used in its relative valuation, which is a method of valuing Illumina by comparing valuation metrics of similar companies.
Illumina is currently under evaluation in net income category among its peers.

Illumina ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Illumina's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Illumina's managers, analysts, and investors.
Environmental
Governance
Social

Illumina Institutional Holders

Institutional Holdings refers to the ownership stake in Illumina that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Illumina's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Illumina's value.
Shares
Bank Of New York Mellon Corp2025-06-30
2.3 M
Guardcap Asset Management Limited2025-06-30
M
Primecap Management Company2025-06-30
M
Bank Of America Corp2025-06-30
1.9 M
Hhg Plc2025-06-30
1.9 M
Ubs Asset Mgmt Americas Inc2025-06-30
1.8 M
Baillie Gifford & Co Limited.2025-06-30
1.7 M
Northern Trust Corp2025-06-30
1.6 M
Edmond De Rothschild Holding S.a.2025-06-30
1.4 M
Blackrock Inc2025-06-30
19.4 M
Capital World Investors2025-06-30
16.6 M

Illumina Fundamentals

About Illumina Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Illumina's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Illumina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Illumina based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Illumina

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.

Moving together with Illumina Stock

  0.73WAT WatersPairCorr

Moving against Illumina Stock

  0.75PBCRY Bank Central AsiaPairCorr
  0.72CDXS CodexisPairCorr
  0.68TEM Tempus AI ClassPairCorr
  0.53PTAIF PT Astra InternationalPairCorr
  0.33BKRKF PT Bank RakyatPairCorr
The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.
The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:
Check out Illumina Piotroski F Score and Illumina Altman Z Score analysis.
To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Will Life Sciences Tools & Services sector continue expanding? Could Illumina diversify its offerings? Factors like these will boost the valuation of Illumina. Market participants price Illumina higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Illumina data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.78)
Earnings Share
4.46
Revenue Per Share
27.356
Quarterly Revenue Growth
0.004
Return On Assets
0.0915
Illumina's market price often diverges from its book value, the accounting figure shown on Illumina's balance sheet. Smart investors calculate Illumina's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Illumina's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.